Cryptides: Buried secrets in proteins

Peptides

Volumn 28, Issue 12, 2007, Pages 2403-2410

  Pimenta, Daniel C ^a   Lebrun, Ivo ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Crypteins; Cryptides; Cryptome; Peptides; Peptidome; Proteome

Indexed keywords

CRYPTOME; HEMORPHIN DERIVATIVE; ORPOTRIN; PEPTIDOME; PROTEIN SOYMETIDE; PROTEOME; UNCLASSIFIED DRUG;

FUNCTIONAL PROTEOMICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW;

ANIMALS; EVOLUTION, MOLECULAR; HUMANS; PEPTIDE HORMONES; PEPTIDE HYDROLASES; PEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS;

EID: 36148988384     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.10.005     Document Type: Review

References (56)

1. Andrews P.R., Carson J.M., Caselli A., Spark M.J., and Woods R. Conformational analysis and active site modelling of angiotensin-converting enzyme inhibitors. J Med Chem 28 (1985) 393-399
2. Autelitano D.J., Rajic A., Smith A.I., Berndt M.C., Ilag L.L., and Vadas M. The cryptome: a subset of the proteome, comprising cryptic peptides with distinct bioactivities. Drug Discov Today 11 (2006) 306-314
3. Bae Y.S., Bae H., Kim Y., Lee T.G., Suh P.G., and Ryu S.H. Identification of novel chemoattractant peptides for human leukocytes. Blood 97 (2001) 2854-2862
4. Betzel C., Genov N., Rajashankar K.R., and Singh T.P. Modulation of phospholipase A2 activity generated by molecular evolution. Cell Mol Life Sci 56 (1999) 384-397
5. Brantl V., Gramsch C., Lottspeich F., Mertz R., Jaeger K.H., and Herz A. Novel opioid peptides derived from hemoglobin: hemorphins. Eur J Pharmacol 125 (1986) 309-310
6. Cohen M., Fruitier-Arnaudin I., Sauvan R., Birnbaum D., and Piot J.M. Serum levels of hemorphin-7 peptides in patients with breast cancer. Clin Chim Acta 337 (2003) 59-67
7. Conceicao K., Konno K., Melo R.L., Marques E.E., Hiruma-Lima C.A., Lima C., et al. Orpotrin: a novel vasoconstrictor peptide from the venom of the Brazilian stingray Potamotrygon gr. orbignyi. Peptides 27 (2006) 3039-3046
8. Cushman D.W., and Ondetti M.A. History of the design of captopril and related inhibitors of angiotensin-converting enzyme. Hypertension 17 (1991) 589-592
9. Dagouassat N., Garreau I., Zhao Q., Sannier F., and Piot J.M. Kinetic of in vitro generation of some hemorphins: early release of LVV-hemorphin-7, precursor of VV-hemorphin-7. Neuropeptides 30 (1996) 1-5
10. Davis M.T., and Patterson S.D. Does the serum peptidome reveal hemostatic dysregulation?. Ernst Schering Res Found Workshop 61 (2007) 23-44
11. Eck R.V., and Dayhoff M.O. Atlas of protein sequence and structure (1966), National Biomedical Research Foundation, Silver Springs, MD
12. Erdos E.G. The discovery of captopril: reply. FASEB J 18 (2004) 226
13. Ferro E.S., Hyslop S., and Camargo A.C. Intracellullar peptides as putative natural regulators of protein interactions. J Neurochem 91 (2004) 769-777
14. Fruiter-Arnaudin I.I., Cohen M.M., Nervi S.S., Bordenave S.S., Sannier F.F., and Piot J.M. Reduced level of opioid peptides, hemorphin-7 peptides, in serum of diabetic patients. Diabetes Care 26 (2003) 2480
15. Fruitier-Arnaudin I., Cohen M., Coitoux C., and Piot J.M. In vitro metabolism of LVV-hemorphin-7 by renal cytosol and purified prolyl endopeptidase. Peptides 24 (2003) 1201-1206
16. Garreau I., Cucumel K., Dagouassat N., Zhao Q., Cupo A., and Piot J.M. Hemorphin peptides are released from hemoglobin by cathepsin D. Radioimmunoassay against the C-part of V-V-hemorphin-7: an alternative assay for the cathepsin D activity. Peptides 18 (1997) 293-300
17. Gavras H. The discovery of captopril: reply. FASEB J 18 (2004) 225
18. Higgins D., Thompson J., Gibson T., Thompson J.D., Higgins D.G., Gibson T.J., et al. Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22 (1994) 4673-4680
19. Hillier L.W., Coulson A., Murray J.I., Bao Z., Sulston J.E., and Waterston R.H. Genomics in C. elegans: so many genes, such a little worm. Genome Res 15 (2005) 1651-1660
20. Hirabayashi J., Arata Y., and Kasai K. Glycome project: concept, strategy and preliminary application to Caenorhabditis elegans. Proteomics 1 (2001) 295-303
21. Ianzer D., Konno K., Marques-Porto R., Vieira Portaro F.C., Stocklin R., Martins de Camargo A.C., et al. Identification of five new bradykinin potentiating peptides (BPPs) from Bothrops jararaca crude venom by using electrospray ionization tandem mass spectrometry after a two-step liquid chromatography. Peptides 25 (2004) 1085-1092
22. Ianzer D., Konno K., Xavier C.H., Stocklin R., Santos R.A., de Camargo A.C., et al. Hemorphin and hemorphin-like peptides isolated from dog pancreas and sheep brain are able to potentiate bradykinin activity in vivo. Peptides 27 (2006) 2957-2966
23. Ivanov V.T., Karelin A.A., Philippova M.M., Nazimov I.V., and Pletnev V.Z. Hemoglobin as a source of endogenous bioactive peptides: the concept of tissue-specific peptide pool. Biopolymers 43 (1997) 171-188
24. Ivanov V.T., Karelin A.A., and Yatskin O.N. Generation of peptides by human erythrocytes: facts and artifacts. Biopolymers 80 (2005) 332-346
25. Ivanov V.T., and Yatskin O.N. Peptidomics: a logical sequel to proteomics. Expert Rev Proteomics 2 (2005) 463-473
26. Kaddurah-Daouk R., McEvoy J., Baillie R.A., Lee D., Yao J.K., Doraiswamy P.M., et al. Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol Psychiatry 12 (2007) 934-945
27. Katz A.M. Angiotensin II: hemodynamic regulator or growth factor?. J Mol Cell Cardiol 22 (1990) 739-747
28. Kumar S., Tamura K., and Nei M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinformatics 5 (2004) 150-163
29. Lantz I., Glämsta E.L., Talbäck L., and Nyberg F. Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity. FEBS Lett 287 (1991) 39-41
30. Liebmann C., Schrader U., and Brantl V. Opioid receptor affinities of the blood-derived tetrapeptides hemorphin and cytochrophin. Eur J Pharmacol 166 (1989) 523-526
31. McCrudden C.M., Zhou M., Chen T., O'rourke M., Walker B., Hirst D., et al. The complex array of bradykinin-related peptides (BRPs) in the peptidome of pickerel frog (Rana palustris) skin secretion is the product of transcriptional economy. Peptides 28 (2007) 1275-1281
32. Murayama N., Hayashi M.A., Ohi H., Ferreira L.A., Hermann V.V., Saito H., et al. Cloning and sequence analysis of a Bothrops jararaca cDNA encoding a precursor of seven bradykinin-potentiating peptides and a C-type natriuretic peptide. Proc Natl Acad Sci USA 94 (1997) 1189-1193
33. Nei M., and Kumar S. Molecular evolution and phylogenetics (2000), Oxford University Press, New York
34. Ng J.H., and Ilag L.L. Cryptic protein fragments as an emerging source of peptide drugs. IDrugs 9 (2006) 343-346
35. Oliver S.G., Winson M.K., Kell D., and Baganz B.F. Systematic functional analysis of the yeast genome. Trends Biotechnol 16 (1988) 373-378
36. Opie L.H., and Kowolik H. The discovery of captopril: from large animals to small molecules. Cardiovasc Res 30 (1995) 18-25
37. Pimenta D.C., Prezoto B.C., Konno K., Melo R.L., Furtado M.F., Camargo A.C., et al. Mass spectrometric analysis of the individual variability of Bothrops jararaca venom peptide fraction. Evidence for sex-based variation among the bradykinin-potentiating peptides. Rapid Commun Mass Spectrom 21 (2007) 1034-1042
38. Piot J.M., Zhao Q., Guillochon D., Ricart G., and Thomas D. Isolation and characterization of two opioid peptides from a bovine hemoglobin peptic hydrolysate. Biochem Biophys Res Commun 189 (1992) 101-110
39. Rawlings N.D., Morton F.R., and Barrett A.J. MEROPS: the peptidase database. Nucleic Acids Res 34 (2006) D270-D272
40. Rioli V., Gozzo F.C., Heimann A.S., Linardi A., Krieger J.E., Shida C.S., et al. Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme. J Biol Chem 278 (2003) 8547-8555
41. Schally A.V., Baba Y., Nair R.M., and Bennett C.D. The amino acid sequence of a peptide with growth hormone-releasing activity isolated from porcine hypothalamus. J Biol Chem 246 (1971) 6647-6650
42. Schechter I., and Berger A. On the size of the active site in proteases I. Papain. Biochem Biophys Res Commun 27 (1967) 157-162
43. Schomburg I., Chang A., Ebeling C., Gremse M., Heldt C., Huhn G., et al. BRENDA, the enzyme database: updates and major new developments. Nucleic Acids Res 32 (2004) D431-D433
44. Scully M.F. Plasma peptidome: a new approach for assessing thrombotic risk?. Thromb Haemost 96 (2006) 697
45. Smith C.G., and Vane J.R. The discovery of captopril. FASEB J 17 (2003) 788-789
46. Smith C.G., and Vane J.R. The discovery of captopril: a reply. FASEB J 18 (2004) 935
47. The Arabidopsis Genome Initiative. Analysis of the genome sequence of the flowering plant Arabidopsis thaliana. Nature 408 (2000) 796-815
48. Tsuruki T., Kishi K., Takahashi M., Tanaka M., Matsukawa T., Yoshikawa M., et al. An immunostimulating peptide derived from soybean beta-conglycinin, is an fMLP agonist. FEBS Lett 540 (2003) 206-210
49. Ueki N., Someya K., Matsuo Y., Wakamatsu K., and Mukai H. Cryptides: functional cryptic peptides hidden in protein structures. Biopolymers 88 (2007) 190-198
50. Valet G. Cytomics: an entry to biomedical cell systems biology. Cytometry A 63 (2005) 67-68
51. Veber D.F., Bennett C.D., Milkowski J.D., Gal G., Denkewalter R.G., and Hirschmann R. Synthesis of a proposed growth hormone releasing factor. Biochem Biophys Res Commun 45 (1971) 235-239
52. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., et al. The sequence of the human genome. Science 291 (2001) 1304-1351
53. Wasinger V.C., Cordwell S.J., Cerpa-Poljak A., Yan J.X., Gooley A.A., Wilkins M.R., et al. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 16 (1995) 1090-1094
54. Wilkins M.R., Sanchez J.C., Williams K.L., and Hochstrasser D.F. Current challenges and future applications for protein maps and post-translational vector maps in proteome projects. Electrophoresis 17 (1996) 830-838
55. Zhao Q., and Piot J.M. Investigation of inhibition angiotensin-converting enzyme (ACE) activity and opioid activity of two hemorphins, LVV-hemorphin-5 and VV-hemorphin-5, isolated from a defined peptic hydrolysate of bovine hemoglobin. Neuropeptides 31 (1997) 147-153
56. Zhao Q., Sannier F., Garreau I., Guillochon D., and Piot J.M. Inhibition and inhibition kinetics of angiotensin converting enzyme activity by hemorphins, isolated from a peptic bovine hemoglobin hydrolysate. Biochem Biophys Res Commun 204 (1994) 216-223